Skip to main content
Log in

Mylan's valsartan products banned from EU medicines

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. NDEA = N-nitrosodiethylamine

  2. CEP is a certificate of compliance with European standards for quality testing.

  3. Also see Reactions 1711 p2; 803335025, see Reactions 1715 p1; 803341056, see Reactions 1717 p3; 803343140 and see Reactions 1725 p1; 803353257

Reference

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mylan's valsartan products banned from EU medicines. Reactions Weekly 1730, 2 (2018). https://doi.org/10.1007/s40278-018-54902-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-018-54902-8

Navigation